M&A Deal Summary

Chemo Group Acquires Everett Laboratories

On March 16, 2010, Chemo Group acquired medical products company Everett Laboratories from Mangrove Equity Partners for 40M USD

Acquisition Highlights
  • This is Chemo Group’s 1st transaction in the Medical Products sector.
  • This is Chemo Group’s largest (disclosed) transaction.
  • This is Chemo Group’s 1st transaction in the United States.
  • This is Chemo Group’s 1st transaction in New Jersey.

M&A Deal Summary

Date 2010-03-16
Target Everett Laboratories
Sector Medical Products
Buyer(s) Chemo Group
Sellers(s) Mangrove Equity Partners
Deal Type Add-on Acquisition
Deal Value 40M USD

Target

Everett Laboratories

West Orange, New Jersey, United States
website
Everett Laboratories, Inc. developer and marketer of patented, prescription nutraceutical products. Everett’s innovative products include more palatable and tolerable prenatal vitamins and other nutritional support products for patients in various health states.

Search 190,634 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Chemo Group

Barcelona, Spain

website


Category Company
Sector Life Science
DESCRIPTION

Chemo Group is a Spanish multinational pharmaceutical company specialized in the research into, and the manufacture and marketing of active ingredients and pharmaceutical products.


DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (New Jersey) 1 of 1
Country (United States) 1 of 1
Year (2010) 1 of 1
Size (of disclosed) 1 of 1

Seller(S) 1

SELLER

Mangrove Equity Partners

Tampa, Florida, United States

Investor Investor Investor Investor Investor

website


Category Private Equity Firm
Founded 2007
Size Small
Type Sector Agnostic
DESCRIPTION

Mangrove Equity Partners is a lower-middle market private equity firm focused on investing in North American businesses valued from $10 to $50 million. Mangrove generally targets companies operating in basic industries with defensible market positions and solid growth prospects. Sectors of interest include services, manufacturing, and value-added distribution. Prospective businesses typically have revenues up to $100 million and are profitable with at least $2 million of cash-flow. Target transaction types include management buyouts/buy-ins, recapitalizations, industry, consolidations, family successions, and select turnarounds. Mangrove Equity Partners is based in Tampa, Florida.


DEAL STATS #
Overall 1 of 12
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 10
State (New Jersey) 1 of 1
Country (United States) 1 of 11
Year (2010) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2010-01-13 Gayesco International

Pasadena, Texas, United States

Gayesco International (GI) is a manufacturer of systems and components that are used to improve the efficiency and safety of petroleum refineries worldwide, by providing critically accurate temperature measurement throughout various refinery-processing tanks.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-08-26 Integrated Global Services

Richmond, Virginia, United States

Integrated Global Services is a provider of highly engineered, proprietary surface protection solutions and technologies to a diversified global customer base. The Company’s technologies and services solve metal wastage and reliability problems in mission-critical equipment found across energy, power generation and other industrial end markets.

Buy -